tiprankstipranks
Edwards Lifesciences Corp. (CH:EW)
NYSE:EW
Switzerland Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports

Edwards Lifesciences (EW) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

EW Analyst Ratings

Strong Buy
20Ratings
Strong Buy
16 Buy
4 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Edwards
Lifesciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EW Stock 12 Month Forecast

Average Price Target

CHF77.98
▲(13.39% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is CHF77.98 with a high forecast of CHF87.17 and a low forecast of CHF67.36. The average price target represents a 13.39% change from the last price of CHF68.77.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"CHF66","77":"CHF77","88":"CHF88","71.5":"CHF71.5","82.5":"CHF82.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":87.1722819,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF87.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.979568536,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF77.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67.36039965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF67.36</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,71.5,77,82.5,88],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.772,70.1874063,71.60281260000001,73.01821890000001,74.43362520000001,75.84903150000001,77.2644378,78.6798441,80.0952504,81.5106567,82.926063,84.3414693,85.7568756,{"y":87.1722819,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.772,69.48027450276923,70.18854900553846,70.89682350830769,71.60509801107693,72.31337251384616,73.02164701661539,73.72992151938462,74.43819602215385,75.14647052492307,75.85474502769232,76.56301953046155,77.27129403323077,{"y":77.979568536,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.772,68.66341535769232,68.55483071538463,68.44624607307694,68.33766143076923,68.22907678846154,68.12049214615385,68.01190750384616,67.90332286153847,67.79473821923078,67.68615357692308,67.57756893461539,67.4689842923077,{"y":67.36039965,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":68.772,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.772,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF87.17Average Price TargetCHF77.98Lowest Price TargetCHF67.36
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:EW
Mike Kratky
Leerink Partners
Leerink Partners
CHF68.95
Hold
0.25%
Upside
Assigned
06/16/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Spyre Therapeutics (NASDAQ: SYRE)
Truist Financial Analyst forecast on CH:EW
Richard Newitter
Truist Financial
Truist Financial
―
Hold
―
Reiterated
06/16/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), High Tide (NASDAQ: HITI) and Option Care Health (NASDAQ: OPCH)
Evercore ISI Analyst forecast on CH:EW
Vijay Kumar
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
06/16/26
TAVR NCD proposal 'uber bullish' for Edwards Lifesciences, says Evercore ISITAVR NCD proposal 'uber bullish' for Edwards Lifesciences, says Evercore ISI
William Blair Analyst forecast on CH:EW
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/16/26
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Qiagen (NYSE: QGEN) and Edwards Lifesciences (NYSE: EW)
Bank of America Securities Analyst forecast on CH:EW
Travis Steed
Bank of America Securities
Bank of America Securities
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained
Citi Analyst forecast on CH:EW
Joanne Wuensch
Citi
Citi
CHF80.04
Buy
16.39%
Upside
Reiterated
06/15/26
Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (NYSE: EW), Xencor (NASDAQ: XNCR) and Definitive Healthcare Corp (NASDAQ: DH)
Goldman Sachs Analyst forecast on CH:EW
David Roman
Goldman Sachs
Goldman Sachs
CHF77.66
Buy
12.93%
Upside
Reiterated
06/15/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Vertex Pharmaceuticals (NASDAQ: VRTX) and Kyowa Kirin Co (Other OTC: KYKOF)
RBC Capital Analyst forecast on CH:EW
Shagun Singh Chadha
RBC Capital
RBC Capital
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW)
BTIG Analyst forecast on CH:EW
Marie Thibault
BTIG
BTIG
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
BTIG Sticks to Their Buy Rating for Edwards Lifesciences (EW)
TD Cowen Analyst forecast on CH:EW
Josh Jennings
TD Cowen
TD Cowen
CHF82.42
Buy
19.85%
Upside
Reiterated
06/03/26
Edwards Lifesciences (EW) Receives a Buy from TD Cowen
Jefferies Analyst forecast on CH:EW
Matthew Taylor
Jefferies
Jefferies
CHF80.83
Buy
17.54%
Upside
Reiterated
05/27/26
Jefferies Remains a Buy on Edwards Lifesciences (EW)
Argus Research Analyst forecast on CH:EW
David Toung
Argus Research
Argus Research
―
Buy
―
Reiterated
05/21/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Eli Lilly & Co (LLY)
Piper Sandler Analyst forecast on CH:EW
Adam Maeder
Piper Sandler
Piper Sandler
CHF79.25
Buy
15.24%
Upside
Reiterated
05/05/26
Edwards Lifesciences (EW) Gets a Buy from Piper Sandler
Mizuho Securities Analyst forecast on CH:EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF75.29→CHF79.25
Buy
15.24%
Upside
Reiterated
04/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (NASDAQ: MEDP), Siegfried Holding AG (Other OTC: SGFEF) and Edwards Lifesciences (NYSE: EW)
Robert W. Baird Analyst forecast on CH:EW
David Rescott
Robert W. Baird
Robert W. Baird
CHF67.36→CHF68.95
Hold
0.25%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target raised to $87 from $85 at BairdEdwards Lifesciences price target raised to $87 from $85 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:EW
Mike Kratky
Leerink Partners
Leerink Partners
CHF68.95
Hold
0.25%
Upside
Assigned
06/16/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Spyre Therapeutics (NASDAQ: SYRE)
Truist Financial Analyst forecast on CH:EW
Richard Newitter
Truist Financial
Truist Financial
―
Hold
―
Reiterated
06/16/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), High Tide (NASDAQ: HITI) and Option Care Health (NASDAQ: OPCH)
Evercore ISI Analyst forecast on CH:EW
Vijay Kumar
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
06/16/26
TAVR NCD proposal 'uber bullish' for Edwards Lifesciences, says Evercore ISITAVR NCD proposal 'uber bullish' for Edwards Lifesciences, says Evercore ISI
William Blair Analyst forecast on CH:EW
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/16/26
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Qiagen (NYSE: QGEN) and Edwards Lifesciences (NYSE: EW)
Bank of America Securities Analyst forecast on CH:EW
Travis Steed
Bank of America Securities
Bank of America Securities
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained
Citi Analyst forecast on CH:EW
Joanne Wuensch
Citi
Citi
CHF80.04
Buy
16.39%
Upside
Reiterated
06/15/26
Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (NYSE: EW), Xencor (NASDAQ: XNCR) and Definitive Healthcare Corp (NASDAQ: DH)
Goldman Sachs Analyst forecast on CH:EW
David Roman
Goldman Sachs
Goldman Sachs
CHF77.66
Buy
12.93%
Upside
Reiterated
06/15/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Vertex Pharmaceuticals (NASDAQ: VRTX) and Kyowa Kirin Co (Other OTC: KYKOF)
RBC Capital Analyst forecast on CH:EW
Shagun Singh Chadha
RBC Capital
RBC Capital
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW)
BTIG Analyst forecast on CH:EW
Marie Thibault
BTIG
BTIG
CHF79.25
Buy
15.24%
Upside
Reiterated
06/15/26
BTIG Sticks to Their Buy Rating for Edwards Lifesciences (EW)
TD Cowen Analyst forecast on CH:EW
Josh Jennings
TD Cowen
TD Cowen
CHF82.42
Buy
19.85%
Upside
Reiterated
06/03/26
Edwards Lifesciences (EW) Receives a Buy from TD Cowen
Jefferies Analyst forecast on CH:EW
Matthew Taylor
Jefferies
Jefferies
CHF80.83
Buy
17.54%
Upside
Reiterated
05/27/26
Jefferies Remains a Buy on Edwards Lifesciences (EW)
Argus Research Analyst forecast on CH:EW
David Toung
Argus Research
Argus Research
―
Buy
―
Reiterated
05/21/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Eli Lilly & Co (LLY)
Piper Sandler Analyst forecast on CH:EW
Adam Maeder
Piper Sandler
Piper Sandler
CHF79.25
Buy
15.24%
Upside
Reiterated
05/05/26
Edwards Lifesciences (EW) Gets a Buy from Piper Sandler
Mizuho Securities Analyst forecast on CH:EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF75.29→CHF79.25
Buy
15.24%
Upside
Reiterated
04/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (NASDAQ: MEDP), Siegfried Holding AG (Other OTC: SGFEF) and Edwards Lifesciences (NYSE: EW)
Robert W. Baird Analyst forecast on CH:EW
David Rescott
Robert W. Baird
Robert W. Baird
CHF67.36→CHF68.95
Hold
0.25%
Upside
Reiterated
04/24/26
Edwards Lifesciences price target raised to $87 from $85 at BairdEdwards Lifesciences price target raised to $87 from $85 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Edwards Lifesciences

3 Months
Adam MaederPiper Sandler
Success Rate
18/27 ratings generated profit
67%
Average Return
+1.55%
Copying Adam Maeder's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.55% per trade.
1 Year
Adam MaederPiper Sandler
Success Rate
22/27 ratings generated profit
81%
Average Return
+8.66%
Copying Adam Maeder's trades and holding each position for 1 Year would result in 81.48% of your transactions generating a profit, with an average return of +8.66% per trade.
2 Years
Larry BiegelsenWells Fargo
Success Rate
15/21 ratings generated profit
71%
Average Return
+10.61%
Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +10.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EW Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
49
36
35
30
37
Hold
18
11
11
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
67
47
46
33
42
In the current month, EW has received 37 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the past 3 months is 77.98.
Each month's total comprises the sum of three months' worth of ratings.

EW Financial Forecast

EW Earnings Forecast

Next quarter’s earnings estimate for EW is CHF0.59 with a range of CHF0.58 to CHF0.61. The previous quarter’s EPS was CHF0.62. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s earnings estimate for EW is CHF0.59 with a range of CHF0.58 to CHF0.61. The previous quarter’s EPS was CHF0.62. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Sales Forecast

Next quarter’s sales forecast for EW is CHF1.35B with a range of CHF1.34B to CHF1.37B. The previous quarter’s sales results were CHF1.31B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s sales forecast for EW is CHF1.35B with a range of CHF1.34B to CHF1.37B. The previous quarter’s sales results were CHF1.31B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Stock Forecast FAQ

What is CH:EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences Corp.’s 12-month average price target is 77.98.
    What is CH:EW’s upside potential, based on the analysts’ average price target?
    Edwards Lifesciences Corp. has 13.39% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Edwards Lifesciences Corp. a Buy, Sell or Hold?
          Edwards Lifesciences Corp. has a consensus rating of Strong Buy, which is based on 16 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Edwards Lifesciences Corp.’s share price target?
            The average share price target for Edwards Lifesciences Corp. is 77.98. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF87.17 ,and the lowest forecast is CHF67.36. The average share price target represents 13.39% Increase from the current price of CHF68.77.
              What do analysts say about Edwards Lifesciences Corp.?
              Edwards Lifesciences Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of Edwards Lifesciences Corp.?
                To buy shares of CH:EW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.